16-29968171-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001083613.2(TMEM219):c.502G>A(p.Ala168Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000276 in 1,614,054 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001083613.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM219 | NM_001083613.2 | c.502G>A | p.Ala168Thr | missense_variant | 4/6 | ENST00000279396.11 | NP_001077082.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM219 | ENST00000279396.11 | c.502G>A | p.Ala168Thr | missense_variant | 4/6 | 1 | NM_001083613.2 | ENSP00000279396 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000217 AC: 33AN: 152166Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000369 AC: 92AN: 249576Hom.: 0 AF XY: 0.000273 AC XY: 37AN XY: 135406
GnomAD4 exome AF: 0.000283 AC: 413AN: 1461888Hom.: 0 Cov.: 31 AF XY: 0.000259 AC XY: 188AN XY: 727248
GnomAD4 genome AF: 0.000217 AC: 33AN: 152166Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74340
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 26, 2022 | The c.502G>A (p.A168T) alteration is located in exon 4 (coding exon 3) of the TMEM219 gene. This alteration results from a G to A substitution at nucleotide position 502, causing the alanine (A) at amino acid position 168 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at